Antisense Bcl-2 Oligonucleotide Uptake in Human Transitional Cell Carcinoma.

B.J. Duggan, F.E. Cotter, J.D. Kelly, Peter Hamilton, K. McCallion, Denis Harkin, Tom Gardiner, Neil H Anderson, P. Keane, S Robin Johnston, Kathleen Williamson

Research output: Contribution to journalArticlepeer-review

14 Citations (Scopus)

Abstract

Objectives; Antisense oligonucleotides (AO) downregulate Bcl-2 protein expression in various tumours if good target cell uptake is achieved. In this study, uptake of FITC labelled AO (FITC-AO) directed at Bcl-2 was examined in; (1) the RT4 bladder tumour cell line (2) normal pig urothelium and (3) human superficial bladder tumours. Methods; In the RT4 cell line, uptake of FITC-AO, FITC-scrambled and FITC-sense oligonucleotides were quantified by flow cytometry at 4h intervals over 24h. Uptake of FITC-AO was assessed in normal pig urothelium by flow cytometry after FITC-AO was infused for 1h. Uptake of FITC AO was assessed in samples from 14 human superficial bladder tumours which were maintained in an ex vivo model. In samples from 6 tumours, uptake at 4h was assessed using fluorescence microscopy. In samples from 8 separate tumours uptake every 4h within the first 24h incubation period was assessed by flow cytometry. Results; In the RT4 cell line the FITC-AO, FITC-scrambled and FITC-sense oligonucleotide uptake was similar. Disaggregated cells from the normal urothelium of the three pigs exhibited 33%, 46%, 51% of cells staining positively for FITC-AO as determined by flow cytometry. All 6 tumour samples had detectable intracellular FITC-AO by fluorescence microscopy at 4h. In the 8 tumours ,examined over the 24h incubation period, there was a range of percentages of positively staining cells. However, most tumours had a monotonic increase in intracellular fluorescence intensity that plateaued 16h post infusion. Conclusion; Antisense Bcl-2 oligonucleotides were readily taken up by superficial bladder cancer cells but the heterogenous uptake in tumour samples needs to be considered when assessing the bioavailability of these drugs.
Original languageEnglish
Pages (from-to)685-695
Number of pages11
JournalEuropean Urology
Volume40(6)
Issue number6
DOIs
Publication statusPublished - Jun 2001

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Antisense Bcl-2 Oligonucleotide Uptake in Human Transitional Cell Carcinoma.'. Together they form a unique fingerprint.

Cite this